Drug intelligence / Profile preview

ALLO-ASC-DFU

Development stage
Unknown
Lead developer
Anterogen
Modality
Hydrogel Systems → Drug Delivery Systems, Stem Cell Therapies → Cell Therapies
Administration
Topical, Intralesional, Subcutaneous, Intraarticular, Intratendinous, Rectal
01

Overview

ALLO-ASC-DFU is an allogeneic cell therapy developed by Anterogen Co., Ltd., consisting of a hydrogel sheet impregnated with allogeneic adipose-derived mesenchymal stem cells (ASCs). The therapy is designed to treat chronic or severe wounds, such as diabetic foot ulcers (DFU), dystrophic epidermolysis bullosa (DEB), and deep second-degree burns. The ASCs within the hydrogel sheet exert anti-inflammatory effects and secrete essential growth factors, including vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). These factors promote angiogenesis, enhance wound healing, and stimulate the regeneration of new tissue. The hydrogel sheet formulation provides a moist environment and a scaffold for the cells to interact with the wound bed, facilitating the delivery of therapeutic factors directly to the site of injury.

Brand names
ALLO-ASC-SHEET
Other names
Allogenic adipose-derived mesenchymal stem cellsallo-asc

Beyond the preview

Go deeper on ALLO-ASC-DFU.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALLO-ASC-DFU.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call